Vischer with Blue Owl on loan facility to Madrigal
Vischer advised globally active asset manager Blue Owl on an up to USD 500 million term loan facility for Madrigal Pharmaceuticals, a biopharmaceutical company specialised in therapeutics for metabolic dysfunction-associated steatohepatitis.
The Vischer team
Adrian Dörig (pictured) led the Vischer team on the matter, working alongside Christian Schneiter and Balthasar Müller (all financing) as well as Christoph Niederer (tax).